In contrast, the TREC content on the single cell level in naïve CD4+CD25high Treg cells in colorectal cancer patients was more than two-fold higher in average compared to healthy individuals before initiation of chemoimmunotherapy and even more increased after administration of IL-2 (>4–fold in average, Fig. 5C). This evidence concerns the gene CD4 and colorectal cancer.